Lyka Labs · NSE: LYKALABS · BSE: 500259

Q3 FY22 results · Oct–Dec 2021

Lyka Labs reported revenue from operations of ₹35.57 crore (up 32.7% from Q3 FY21) and net profit of ₹6.09 crore for Q3 FY22 (Oct–Dec 2021), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY22Q3 FY21YoYQ2 FY22QoQ
Revenue from operations35.5726.81+32.7%73.89−51.9%
Other income0.410.28+42.4%0.69−40.8%
Total income35.9827.10+32.8%74.57−51.8%
Profit before share of associates & JVs and tax6.72(1.99)Turned profit33.33−79.8%
Share of profit/(loss) of associates & JVs(0.19)0.000.00
Net profit for the period6.09(1.86)Turned profit27.68−78.0%
EPS, basic (₹)2.11(0.80)Turned profit9.90−78.7%
Net margin (%)17.1-6.937.5

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ3 FY22Q3 FY21YoYQ2 FY22QoQ
Revenue from operations28.1818.91+49.0%65.02−56.7%
Other income0.670.40+69.9%0.86−21.4%
Total income28.8619.31+49.4%65.87−56.2%
Profit before tax6.06(3.21)Turned profit35.41−82.9%
Net profit for the period5.68(3.06)Turned profit29.81−80.9%
EPS, basic (₹)1.97(1.80)Turned profit10.38−81.0%
Net margin (%)20.2-16.245.9
Consolidated
Filed with BSE
20 Jan 2022, 19:50 IST
Board meeting
20 Jan 2022
Period
01 Oct 2021 to 31 Dec 2021
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
20 Jan 2022, 19:50 IST
Board meeting
20 Jan 2022
Period
01 Oct 2021 to 31 Dec 2021
Review status
Unaudited
Source
XBRL filing on BSE